Danaher Corporation (DHR)
What changed this quarter
- Institutions — 1 reduced
- Risk factors — 1 removed · removed: Our restructuring actions and other cost re…
- Debt-to-equity 0.3x → 0.3x
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Company overview
Danaher. A life-sciences and diagnostics conglomerate. It has achieved compounding growth via a high-margin consumables business and continuous acquisitions.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Danaher Corporation is classified under the Biotech & Health sector. See peers below.
Danaher Corporation key financials
Based on SEC filings · latest quarter (TTM)
Tap a metric name to see its meaning in the glossary.
DHR segment revenue mix trend
Quarterly change in segment revenue share · verified from SEC filings
ETFs holding Danaher Corporation
Per SEC N-PORT · 2026-03-31 · by weight · factual
DHR on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — valuation and growth vs the Biotech & Health average
Peers · Biotech & Health
DHR FAQ
What is Danaher Corporation (DHR)?
Danaher. A life-sciences and diagnostics conglomerate. It has achieved compounding growth via a high-margin consumables business and continuous acquisitions.
What sector is Danaher Corporation in?
Danaher Corporation is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are Danaher Corporation's key financials?
Based on the latest quarter (TTM) from SEC filings: Revenue growth (YoY) 4.6%, Operating margin 18.0%, Net margin 15.9%, ROE 6.9%, Debt-to-equity 0.35x. Definitions and interpretation are available on Stocklore.
Where can I analyze Danaher Corporation (DHR) stock?
On Stocklore you can see DHR's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, 45-day delay), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.